149 related articles for article (PubMed ID: 29568397)
1. Nucleolar stress enhances lytic reactivation of the Kaposi's sarcoma-associated herpesvirus.
Gelgor A; Gam Ze Letova C; Yegorov Y; Kalt I; Sarid R
Oncotarget; 2018 Mar; 9(17):13822-13833. PubMed ID: 29568397
[TBL] [Abstract][Full Text] [Related]
2. Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.
Aneja KK; Yuan Y
Front Microbiol; 2017; 8():613. PubMed ID: 28473805
[TBL] [Abstract][Full Text] [Related]
3. ZIC2 Is Essential for Maintenance of Latency and Is a Target of an Immediate Early Protein during Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
Lyu Y; Nakano K; Davis RR; Tepper CG; Campbell M; Izumiya Y
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835494
[TBL] [Abstract][Full Text] [Related]
4. Lytic Reactivation of the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations.
Atari N; Rajan KS; Chikne V; Cohen-Chalamish S; Doniger T; Orbaum O; Jacob A; Kalt I; Michaeli S; Sarid R
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016343
[TBL] [Abstract][Full Text] [Related]
5. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.
Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ
J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721
[TBL] [Abstract][Full Text] [Related]
6. Gallic acid inhibits Kaposi's Sarcoma-associated herpesvirus lytic reactivation by suppressing RTA transcriptional activities.
Long WY; Zhao GH; Wu Y; Liu Y
Food Sci Nutr; 2021 Feb; 9(2):847-854. PubMed ID: 33598168
[TBL] [Abstract][Full Text] [Related]
7. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
Vieira J; O'Hearn PM
Virology; 2004 Aug; 325(2):225-40. PubMed ID: 15246263
[TBL] [Abstract][Full Text] [Related]
8. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation.
Olson AT; Kang Y; Ladha AM; Lim CB; Lagunoff M; Gujral TS; Geballe AP
bioRxiv; 2023 Feb; ():. PubMed ID: 36778430
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
11. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
12. KSHV Rta Promoter Specification and Viral Reactivation.
Guito J; Lukac DM
Front Microbiol; 2012; 3():30. PubMed ID: 22347875
[TBL] [Abstract][Full Text] [Related]
13. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
Liang Y; Ganem D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
[TBL] [Abstract][Full Text] [Related]
14. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus.
González CM; Wong EL; Bowser BS; Hong GK; Kenney S; Damania B
J Virol; 2006 Mar; 80(6):3062-70. PubMed ID: 16501115
[TBL] [Abstract][Full Text] [Related]
17. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
Yang Z; Wood C
J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.
Xu D; Coleman T; Zhang J; Fagot A; Kotalik C; Zhao L; Trivedi P; Jones C; Zhang L
J Virol; 2007 Jun; 81(11):6068-78. PubMed ID: 17376914
[TBL] [Abstract][Full Text] [Related]
19. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
20. Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator.
Chen J; Ueda K; Sakakibara S; Okuno T; Parravicini C; Corbellino M; Yamanishi K
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4119-24. PubMed ID: 11274437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
